Medtronic has agreed to pay $4.41 million to settle allegations that it sold to the U.S. Government medical devices and instruments that did not meet Trade Agreements Act requirements:

According to the settlement agreement, between 2007 and 2014, Medtronic sold to the VA and DoD products it certified would be made in the United States or other designated countries.  The Trade Agreements Act of 1979 (TAA) generally requires companies selling products to the United States to manufacture them in the United States or in another designated country.  The United States alleged that Medtronic sold to the United States products manufactured in China and Malaysia, which are prohibited countries under the TAA.

The suit was filed by three whistleblowers, who will receive $749,700 as a reward for bringing the fraud to the government’s attention.

Read the entire press release, “Medtronic to Pay $4.41 Million to Resolve Allegations that it Unlawfully Sold Medical Devices Manufactured Overseas”